Literature DB >> 17415324

Cutaneous and presumed visceral leishmaniasis in a soldier deployed to Afghanistan.

James P Woodrow1, Joshua D Hartzell, Jim Czarnik, David M Brett-Major, Glenn Wortmann.   

Abstract

Leishmaniasis has been frequently diagnosed in US military personnel returning from duty in Southwest Asia. The majority of cases have demonstrated cutaneous disease, although a few cases of visceral disease have been documented. We present the case of an immunocompetent, HIV-negative, US Army soldier who suffered both visceral and cutaneous manifestations of leishmaniasis after returning from deployment in Afghanistan. Overlap of cutaneous and visceral involvement is rare and has not been reported in our cohort. Latent Plasmodium vivax infection may have been an exacerbating cofactor. We discuss this case and present a review of the literature.

Entities:  

Mesh:

Year:  2006        PMID: 17415324      PMCID: PMC1868389     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  35 in total

1.  Kala azar associated with malaria.

Authors:  Shatrughan Prasad Sah; Sanjib Kumar Sharma; Sudha Rani
Journal:  Arch Pathol Lab Med       Date:  2002-03       Impact factor: 5.534

2.  A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis.

Authors:  Marleen Boelaert; Suman Rijal; Sudhir Regmi; Rupa Singh; Balmansingh Karki; Diane Jacquet; François Chappuis; Lenea Campino; Philippe Desjeux; Dominique Le Ray; Shekhar Koirala; Patrick Van der Stuyft
Journal:  Am J Trop Med Hyg       Date:  2004-01       Impact factor: 2.345

3.  Concomitant kala-azar, malaria, and progressive unstable indeterminate leprosy in an 8-year-old child.

Authors:  K Saha; D Chattopadhya; D D Kulpati
Journal:  J Trop Pediatr       Date:  1998-08       Impact factor: 1.165

4.  Combination of malaria and visceral leishmaniasis in a child of two years.

Authors:  H A Farooqui; M Abdul Aziz
Journal:  J Pak Med Assoc       Date:  1984-05       Impact factor: 0.781

5.  Visceral leishmaniasis following a skin lesion in a six-year-old Silician girl.

Authors:  G Schiliro; A Russo; S Musumeci; A Sciotto
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

Review 6.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

7.  Two cases of visceral leishmaniasis in U.S. military personnel--Afghanistan, 2002-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-04-02       Impact factor: 17.586

8.  Cutaneous involvement in a rare case of adult visceral leishmaniasis acquired in Israel.

Authors:  R Ben-Ami; L F Schnur; Y Golan; C L Jaffe; T Mardi; D Zeltser
Journal:  J Infect       Date:  2002-04       Impact factor: 6.072

9.  Short report: Treatment failure due to mixed infection by different strains of the parasite Leishmania infantum.

Authors:  Maria Antoniou; C Doulgerakis; F Pratlong; J P Dedet; Y Tselentis
Journal:  Am J Trop Med Hyg       Date:  2004-07       Impact factor: 2.345

Review 10.  Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

Authors:  Philippe J Guerin; Piero Olliaro; Shyam Sundar; Marleen Boelaert; Simon L Croft; Philippe Desjeux; Monique K Wasunna; Anthony D M Bryceson
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

View more
  4 in total

1.  The antituberculosis drug pyrazinamide affects the course of cutaneous leishmaniasis in vivo and increases activation of macrophages and dendritic cells.

Authors:  Susana Mendez; Ryan Traslavina; Meleana Hinchman; Lu Huang; Patricia Green; Michael H Cynamon; John T Welch
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

2.  Prevalence, features and risk factors for malaria co-infections amongst visceral leishmaniasis patients from Amudat Hospital, Uganda.

Authors:  Erika van den Bogaart; Marieke M Z Berkhout; Emily R Adams; Pètra F Mens; Elizabeth Sentongo; Dawson B Mbulamberi; Masja Straetemans; Henk D F H Schallig; Francois Chappuis
Journal:  PLoS Negl Trop Dis       Date:  2012-04-10

3.  Visceral Leishmaniasis-Malaria Coinfection and Their Associated Factors in Patients Attending Metema Hospital, Northwest Ethiopia: Suggestion for Integrated Vector Management.

Authors:  Getachew Ferede; Ermias Diro; Sisay Getie; Gebeyaw Getnet; Yegnasew Takele; Anteneh Amsalu; Yitayih Wondimeneh
Journal:  Malar Res Treat       Date:  2017-08-28

4.  Cutaneous, mucocutaneous and visceral leishmaniasis in Sweden from 1996-2016: a retrospective study of clinical characteristics, treatments and outcomes.

Authors:  Hedvig Glans; Leif Dotevall; Sara Karlsson Söbirk; Anna Färnert; Maria Bradley
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.